DANIEL MANESH: Open Payments
NPI 1780283234 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,054 in 38 payments from 13 companies in 2025. Trend: 2023 $164 · 2024 $619 · 2025 $1,054
Food & beverage: $1,054
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $233 |
| ACADIA Pharmaceuticals Inc | 1 | $122 |
| Calliditas Therapeutics US Inc. | 4 | $121 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Novo Nordisk Inc | 4 | $103 |
| Amgen Inc. | 5 | $100 |
| Travere Therapeutics, Inc. | 5 | $86 |
| Mallinckrodt Hospital Products Inc. | 2 | $46 |
| Lilly USA, LLC | 2 | $45 |
| AngioDynamics, Inc. | 1 | $25 |
Products named: Kerendia, DAYBUE, TARPEYO, CRYSVITA, Rybelsus, ACTHAR, REPATHA, KRYSTEXXA.
Industry payments across TX — which companies pay providers there.
